Setsuko K Chambers

  • 4502 Citations
  • 42 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Setsuko K Chambers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
fms Genes Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Papillary Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1990 2009

Macrophage Colony-Stimulating Factor
Ovarian Neoplasms
RNA-Binding Proteins
Androgens
Exons
Macrophage Colony-Stimulating Factor
Urokinase-Type Plasminogen Activator
Ovarian Neoplasms
fms Genes
Urokinase Plasminogen Activator Receptors
fms Genes
Macrophage Colony-Stimulating Factor
RNA Stability
Dexamethasone
Breast Neoplasms
Macrophage Colony-Stimulating Factor
Platinum
Drug Resistance
Macrophage Activation
Macrophage Colony-Stimulating Factor Receptors

Research Output 1986 2019

  • 4502 Citations
  • 42 h-Index
  • 132 Article
  • 3 Chapter
  • 1 Conference contribution
9 Citations (Scopus)

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Lin, K. K., Harrell, M. I., Oza, A. M., Oaknin, A., Ray-Coquard, I., Tinker, A. V., Helman, E., Radke, M. R., Say, C., Vo, L. T., Mann, E., Isaacson, J. D., Maloney, L., O'Malley, D. M., Chambers, S. K., Kaufmann, S. H., Scott, C. L., Konecny, G. E., Coleman, R. L., Sun, J. X. & 5 others, Giordano, H., Brenton, J. D., Harding, T. C., McNeish, I. A. & Swisher, E. M., Feb 1 2019, In : Cancer discovery. 9, 2, p. 210-219 10 p.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Mutation
DNA
Neoplasms

Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer

Pandey, R., Woo, H. H., Varghese, F., Zhou, M. & Chambers, S. K., May 1 2019, In : Translational Oncology. 12, 5, p. 714-725 12 p.

Research output: Contribution to journalArticle

Open Access
MicroRNAs
Ovarian Neoplasms
Androgens
Down-Regulation
Serum

Comparison of Reproductive Function in Female TgMISIIR-TAg Transgenic and Wildtype C57BL/6 Mice

Hoyer, P. B., Rice, P. F., Howard, C. C., Koevary, J. W., Dominguez Cooks, J. P., Hutchens, G. V., Chambers, S. K., Craig, Z. R., Connolly, D. C. & Barton, J. K., Feb 1 2019, In : Comparative medicine. 69, 1, p. 16-21 6 p.

Research output: Contribution to journalArticle

Inbred C57BL Mouse
genetically modified organisms
mice
Oncogenic viruses
Animals
1 Citation (Scopus)
Macrophage Colony-Stimulating Factor
RNA Stability
Ovarian Neoplasms
Cells
Breast Neoplasms

Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3′UTR element in CSF-1R mRNA

Woo, H. H., Lee, S. C., Stoffer, J. B., Rush, D. & Chambers, S. K., Jan 1 2019, In : Translational Oncology. 12, 1, p. 106-115 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Phenotype
Messenger RNA
fms Genes
Breast